- Home
- FLYX vs VANI Comparison
FLYX vs VANI Comparison
Compare FLYX & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- VANI
- Stock Information
- Founded
- FLYX 2015
- VANI 1998
- Country
- FLYX United States
- VANI United States
- Employees
- FLYX N/A
- VANI N/A
- Industry
- FLYX Blank Checks
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FLYX Finance
- VANI Health Care
- Exchange
- FLYX Nasdaq
- VANI Nasdaq
- Market Cap
- FLYX 79.8M
- VANI 81.2M
- IPO Year
- FLYX N/A
- VANI 2014
- Fundamental
- Price
- FLYX $3.22
- VANI $1.52
- Analyst Decision
- FLYX
- VANI Strong Buy
- Analyst Count
- FLYX 0
- VANI 1
- Target Price
- FLYX N/A
- VANI $4.00
- AVG Volume (30 Days)
- FLYX 25.5K
- VANI 535.6K
- Earning Date
- FLYX 11-13-2025
- VANI 11-13-2025
- Dividend Yield
- FLYX N/A
- VANI N/A
- EPS Growth
- FLYX N/A
- VANI N/A
- EPS
- FLYX N/A
- VANI N/A
- Revenue
- FLYX $347,746,000.00
- VANI N/A
- Revenue This Year
- FLYX $28.47
- VANI N/A
- Revenue Next Year
- FLYX $22.44
- VANI N/A
- P/E Ratio
- FLYX N/A
- VANI N/A
- Revenue Growth
- FLYX 17.09
- VANI N/A
- 52 Week Low
- FLYX $1.90
- VANI $0.91
- 52 Week High
- FLYX $6.90
- VANI $1.92
- Technical
- Relative Strength Index (RSI)
- FLYX 37.83
- VANI 48.38
- Support Level
- FLYX $3.51
- VANI $1.59
- Resistance Level
- FLYX $4.00
- VANI $1.81
- Average True Range (ATR)
- FLYX 0.37
- VANI 0.14
- MACD
- FLYX -0.02
- VANI -0.03
- Stochastic Oscillator
- FLYX 43.57
- VANI 21.15
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.